TCIM
TIAA CREF Investment Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $565K | Buy |
107,855
+468
| +0.4% | +$2.45K | ﹤0.01% | 2549 |
|
|
2018
Q4 | $338K | Sell |
107,387
-1,319
| -1% | -$4.15K | ﹤0.01% | 2731 |
|
|
2018
Q3 | $658K | Sell |
108,706
-12,242
| -10% | -$74.1K | ﹤0.01% | 2611 |
|
|
2018
Q2 | $641K | Buy |
+120,948
| New | +$641K | ﹤0.01% | 2667 |
|
|
2017
Q2 | – | Sell |
-73,534
| Closed | -$199K | – | 3134 |
|
|
2017
Q1 | $199K | Sell |
73,534
-2,133
| -3% | -$5.77K | ﹤0.01% | 2994 |
|
|
2016
Q4 | $219K | Sell |
75,667
-17,552
| -19% | -$50.8K | ﹤0.01% | 3030 |
|
|
2016
Q3 | $383 | Sell |
93,219
-48,765
| -34% | -$200 | ﹤0.01% | 2945 |
|
|
2016
Q2 | $449K | Buy |
141,984
+32,124
| +29% | +$102K | ﹤0.01% | 2907 |
|
|
2016
Q1 | $568K | Hold |
109,860
| – | – | ﹤0.01% | 2750 |
|
|
2015
Q4 | $1.05M | Hold |
109,860
| – | – | ﹤0.01% | 2548 |
|
|
2015
Q3 | $905K | Buy |
109,860
+29,360
| +36% | +$242K | ﹤0.01% | 2619 |
|
|
2015
Q2 | $1.31M | Buy |
80,500
+54,119
| +205% | +$879K | ﹤0.01% | 2555 |
|
|
2015
Q1 | $1.07M | Buy |
26,381
+3,438
| +15% | +$139K | ﹤0.01% | 2585 |
|
|
2014
Q4 | $1.24M | Buy |
22,943
+2,277
| +11% | +$123K | ﹤0.01% | 2536 |
|
|
2014
Q3 | $707K | Buy |
+20,666
| New | +$707K | ﹤0.01% | 2825 |
|